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Impacts
• Dogs entering Italy had a higher vaccine failure rate than dogs vaccinated in
Italy, raising doubts as to the real compliance with vaccination.
• The choice of vaccine and time of sampling may influence the individual’s
titre level post-vaccination and should be considered when interpreting
serological test results.
• The legislation regulating the free movement of pets needs to be read-
dressed if the risk of spreading rabies has to be minimized.
Keywords:
Rabies; dogs; post-vaccination assessment;
vaccination
Correspondence:
P. De Benedictis. Viale dell’Universitla 10,
35020 Legnaro (PD), Italy. Tel.: +39 049
8084371; Fax: +39 049 8084360; E-mail:
pdebenedictis@izsvenezie.it
Received for publication August 14, 2015
doi: 10.1111/zph.12268
Summary
The current European Union (EU) legislation decrees that pets entering the EU
from a rabies-infected third country have to obtain a satisfactory virus-neutraliz-
ing antibody level, while those moving within the EU require only rabies vaccina-
tion as the risk of moving a rabid pet within the EU is considered negligible. A
number of factors driving individual variations in dog vaccine response have been
previously reported, including a high rate of vaccine failure in puppies, especially
those subject to commercial transport. A total of 21 001 observations collected
from dogs (2006–2012) vaccinated in compliance with the current EU regulations
were statistically analysed to assess the effect of different risk factors related to
rabies vaccine efficacy. Within this framework, we were able to compare the vac-
cination failure rate in a group of dogs entering the Italian border from EU and
non-EU countries to those vaccinated in Italy prior to international travel. Our
analysis identified that cross-breeds and two breed categories showed high vac-
cine success rates, while Beagles and Boxers were the least likely to show a suc-
cessful response to vaccination (88.82% and 90.32%, respectively). Our analysis
revealed diverse performances among the commercially available vaccines, in
terms of serological peak windows, and marked differences according to geo-
graphical area. Of note, we found a higher vaccine failure rate in imported dogs
(13.15%) than in those vaccinated in Italy (5.89%). Our findings suggest that the
choice of vaccine may influence the likelihood of an animal achieving a protective
serological level and that time from vaccination to sampling should be considered
when interpreting serological results. A higher vaccine failure in imported com-
pared to Italian dogs highlights the key role that border controls still have in
assessing the full compliance of pet movements with EU legislation to minimize
the risk of rabies being reintroduced into a disease-free area.
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Introduction
Terrestrial rabies in carnivores has been eliminated in most
industrialized countries through the implementation of
effective control measures. The risk of rabies introduction
into a free area has long been recognized as linked to either
free-roaming wildlife across borders or human-dependent
movement of domestic animals, mainly dogs (Cliquet
et al., 2014). At an international level, quarantine and vac-
cination (alone or coupled with serological testing) are the
two most common approaches to prevent reintroduction
of infection into a rabies-free area.
In Europe, although the risk of moving a rabid pet
within the EU territories is considered negligible (European
Food Safety Authority 2006), the current epidemiological
situation shows an uneven distribution of the disease inci-
dence, especially in wildlife, which highlights the risk of any
country losing its rabies-free status.
The current EU legislation (European Commission
2013) states that pets entering the EU from a third country
have to be accompanied by an international certificate con-
firming a satisfactory virus-neutralizing antibody level. A
serum titre ≥0.5 IU/ml of rabies-neutralizing antibodies is
considered adequately protective against the disease (OIE
World Organization for Animal Health 2013). A titre below
this cut-off is indicative of vaccination failure and could
mean that the vaccination guidelines have not been com-
plied with (such as failure with respect to the minimum
vaccination age, improper vaccine storage and/or adminis-
tration). As noted in the previous literature, primo-vacci-
nation may not induce an adequate serological response in
dogs, depending on risk factors such as the time lapse
between vaccination and testing, the breed, the size, the
age, the type of vaccine and the route of administration
(Cliquet et al., 2003; Mansfield et al., 2004; Kennedy et al.,
2007; Jakel et al., 2008; Zanoni et al., 2010; Berndtsson
et al., 2011). Although individual variations in vaccine
response may partly be due to genotypic differences, such
as those between breeds (Sage et al., 1993; Cliquet et al.,
2003; Kennedy et al., 2007), a high rate of vaccine failure
has been shown in those puppies subject to commercial
transport (Fevre et al., 2006; Tietjen et al., 2011). The Ital-
ian Reference Centre for Rabies (De Benedictis et al., 2008)
has reported a 37% vaccination failure rate in dogs crossing
the Italian border from Eastern European countries.
The aim of this study was to assess the effect of different
risk factors on rabies vaccine efficacy, with special attention
to a group of dogs subject to international transport. To
achieve this, we performed a retrospective analysis of sero-
logical response to rabies vaccination in dogs and then
compared the results of analyses performed on dogs subject
to pre-travel tests departing from Italy to those obtained
during import control testing at the border.
Materials and Methods
Source of sampling and sample selection
Samples were collected between January 2006 and Decem-
ber 2012 on dogs vaccinated against rabies and tested at the
Istituto Zooprofilattico Sperimentale delle Venezie (IZSVe)
for post-vaccination efficacy.
Information relating to the risk factors under investiga-
tion was retrieved from the submission forms and exported
to the survey database (MICROSOFT OFFICE EXCEL worksheet,
Microsoft, Redmond, WA, USA).
For the purposes of our study, only samples with a mini-
mum database of the following information were retained:
date of vaccination, vaccine used, date of sampling and
rabies-neutralizing serum titre. Only those reporting vacci-
nation with the four most represented vaccines in the data-
base were included, to allow reliable comparison studies.
Observations displaying entry errors, inconsistent or
incomplete information were not considered for the analy-
sis. After such omissions, a total of 21 001 observations
were included in the study.
Diagnostic test
For each sample, the serum titre was calculated using the
fluorescent antibody virus neutralization (FAVN) test, as
previously described (Cliquet et al., 1998). A serum titre
≥0.5 IU/ml is considered indicative of protection against
rabies infection (positive outcome) (OIE World Organiza-
tion for Animal Health 2013).
Data sets and statistical analyses
Analyses were conducted using two different data sets,
namely data sets A and B. Data set A included observations
from dogs living in the Italian territory (including the
Republic of San Marino) and sampled before the intended
international travel (n = 20 119; henceforth referred to as
group Italy). Data set B included data set A plus additional
observations from dogs travelling to Italy (n = 882; hence-
forth referred to as group Eastern Europe) and sampled at
the Italian border during routine border control activity.
Dogs in group Eastern Europe came from the following
Eastern European countries: Albania, the Czech Republic,
Hungary, Montenegro, Poland, Romania, Slovakia, includ-
ing Russia, Serbia and Ukraine. None of these countries,
except for the Czech Republic, were free from terrestrial
rabies at the time of sampling.
Variables collated in data set A were as follows: vaccine
used, time from vaccination to sampling (VtS), age at
vaccination, sex, breed, size of the animal and rabies-neu-
tralizing serum titre (test outcome). Less information was
available in terms of associated risk factors for group
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Eastern Europe; thus, in data set B, the variables under
consideration were vaccine used, VtS and rabies-neutraliz-
ing serum titre.
All variables, except for ‘age’, were treated as categorical.
The variables ‘titre’ and ‘sex’ were analysed considering
their outcomes as binary, ˂ or ≥0.5 IU/ml and male or
female, respectively. The variable ‘size’ was categorized into
four groups: small (≤10 kg), medium (11–25 kg), big (26–
44 kg) or giant (≥45 kg). Individuals were allocated to a
specific size category dependent on the average size of the
breed or on the predominant breed in case of cross-breeds,
when reported; otherwise, the information was classified as
‘missing’. Considering that the database included observa-
tions from more than 200 different breeds, the variable
‘breed’ was recategorized following the classification criteria
of the International Canine Federation (FCI-Federation
Cynologique Internationale). Besides cross-breeds, ten breed
categories with similar characteristics were considered and
classified according to the FCI guidelines (Table 1). In
addition, eight breeds of interest (English Setter, Pinscher,
Chihuahua, Maltese, West Highland White Terrier, Ger-
man Shepherd, Boxer and Beagle) were selected from data
set A to evaluate their response to vaccination in compar-
ison with cross-breeds. These breeds were selected as ‘of
interest’ due to either their size or previous evidence of
poor response to vaccination.
The variable ‘VtS’ was classified into six categories
(Table 1). The variable ‘vaccine’ contained four categories
corresponding to four commercially available formulations.
The variable ‘age’ was organized into 11 categories (1-year
categories, up to 10 years), but was included in the model
as a continuous variable.
Descriptive statistics were run to describe the characteris-
tics of the data sets.
Univariate analysis was performed to investigate the
association between each of the variables of interest and the
outcome (titre) using the chi-square test. The strength of
the association was measured through the Cramer V. Cra-
mer V values range between 0 (no association) and 1 (per-
fect association) (Table 1).
Stepwise logistic regression analysis was used to build up
the multivariate models adding one by one the variables
associated with the outcome (P < 0.05 and Cramer’s
V > 0.10). Whenever relevant, interactions between vari-
ables were explored and included in the model. Possible col-
inearity among breed and size variables was contended by
using separate models to explore the effect of each of these
variables on the outcome. P-values <0.05 in the multivariate
analysis were considered as significant. Likelihood ratio and
the Akaike’s Information Criterion (AIC) were used to
compare nested and non-nested models’ fit, respectively.
Overall, four different multivariate models were built to
assess the effect of risk factors in the two data sets (Table 2).
Statistical analyses were performed using STATA 11 (Col-
lege Station, TX, USA: StataCorp LP).
Results
Table 1 reports the descriptive statistics of the overall data
set (group Italy and Eastern Europe) for each variable
included in the study and the results of the univariate anal-
ysis, expressed as Cramer’s V. The majority of observations
in group Italy reported the use of vaccine I (62.51%), while
vaccine IV was the least frequently used (2.06%). The latter
was not reported among the observations outside Italy
(group Eastern Europe), where vaccine II was the most
commonly used (80.38%). Overall, the proportion of suc-
cessful vaccinations (titre ≥ 0.5 IU/ml) was 93.81%
(94.12% and 86.85% in group Italy and Eastern Europe,
respectively) with the majority of animals tested more than
15 days post-vaccination (p.v.). The percentage of vaccina-
tion failure was lower in the observations from group Italy
(5.89%) than in those from group Eastern Europe
(13.15%). When comparing the vaccination success rates in
imported dogs (88.19%) to Italians dogs (91.38%) sampled
>75 days after vaccination, the difference in success rate
was reduced, although still significant (P < 0.001), decreas-
ing from 7.26% to 3.19%.
Univariate analysis
The univariate analysis showed that vaccine protection was
independent from sex (P = 0.399), while all the other vari-
ables were found to be associated with the outcome
(P < 0.001).
The vaccine’s ability to induce a protective titre differed
considerably between the four vaccines in group Italy, with
vaccine II displaying the highest percentage failure (11.13%)
and vaccine IV the lowest (3.13%); vaccines I and III failed
in 3.82% and 5.72% of cases, respectively (Table 1). The chi-
square test demonstrated that the association between type
of vaccine and titre was statistically significant (P < 0.001),
confirming different performances among vaccines.
In group Eastern Europe, the performance also differed
between vaccines (P < 0.001); however, vaccine II had the
second highest performance with 89% of the observations
showing a titre ≥0.5 IU/ml and was the most represented
vaccine in the group (Table 1). Vaccine III, which had only
11 observations, all with a positive outcome, was the most
successfully performing vaccine in group Eastern Europe.
As for VtS, the highest percentage of vaccination success
was observed in dogs sampled from two weeks to two
months following vaccination.
Of note, the number of protected dogs was greater in
cross-breeds (96.29%) than in pure breeds (93.07%). A
more detailed analysis looking at specific FCI categories
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Table 1. Description of the sub-data sets and results of the univariate analysis. Group Italy: observations collected from dogs living in Italy and sam-
pled before the intended travel. Group Eastern Europe: dogs entering Italy from an Eastern European country and subject to frontier control. Missing
data in the database mean that the total number of observations was slightly different among variables
Variables Categories Observations [n (%)] Positive observations*[n (%)] Cramer’s V
Group Italy
Vaccine I 12 577 (62.51) 12 096 (96.18) 0.1340
II 5222 (25.96) 4641 (88.87)
III 1905 (9.47) 1796 (94.28)
IV 415 (2.06) 402 (96.87)
Total 20 119 (100) 18 935 (94.12)
VtSa ≤15 314 (1.56) 293 (93.31) 0.1043
16–30 3131 (15.57) 3011 (96.17)
31–45 5177 (25.74) 5001 (96.60)
46–60 1729 (8.60) 1669 (96.53)
61–75 1074 (5.34) 1018 (94.79)
>75 8685 (43.19) 7936 (91.38)
Total 20 110 (100) 18 928 (94.12)
Breed (FCI)b Cross-breed 3235 (16.14) 3115 (96.29) 0.0611
FCI 1 813 (4.06) 756 (92.99)
FCI 2 1456 (7.27) 1347 (92.51)
FCI 3 1423 (7.10) 1360 (95.57)
FCI 4 386 (1.93) 365 (94.56)
FCI 5 452 (2.26) 404 (89.38)
FCI 6 433 (2.16) 396 (91.45)
FCI 7 8005 (39.95) 7514 (93.87)
FCI 8 1467 (7.32) 1363 (92.91)
FCI 9 2182 (10.89) 2073 (95.00)
FCI 10 186 (0.93) 172 (92.47)
Total 20 038 (100) 18 865 (94.15)
Sizec Small 4958 (26.32) 4734 (95.48) 0.0372
Medium 3503 (18.60) 3285 (93.78)
Big 9823 (52.15) 9180 (93.45)
Giant 552 (2.93) 513 (92.93)
Total 18 836 (100) 17 712 (94.03)
Sex Female 9859 (49.15) 9297 (94.30) (0.0060)
Male 10 201 (50.85) 9591 (94.02)
Total 20 060 (100) 18 888 (94.16)
Aged <1 6411 (32.47) 5791 (90.33) 0.1156
1 3737 (18.93) 3556 (95.16)
2 2341 (11.86) 2250 (96.11)
3 1785 (9.04) 1703 (95.41)
4 1358 (6.88) 1308 (96.32)
5 1007 (5.10) 970 (96.33)
6 862 (4.37) 839 (97.33)
7 671 (3.40) 650 (96.87)
8 519 (2.63) 502 (96.72)
9 368 (1.86) 357 (97.01)
≥10 686 (3.47) 664 (96.79)
Total 19 745 (100) 18 590 (94.15)
Breede Cross-breed 3235 (30.87) 3115 (96.29) 0.0772
Beagle 155 (1.48) 140 (90.32)
German Shepherd 315 (3.01) 290 (92.06)
Boxer 152 (1.45) 135 (88.82)
Chihuahua 332 (3.17) 322 (96.99)
Pinscher 298 (2.84) 287 (96.31)
English Setter 5506 (52.53) 5144 (93.43)
West Highland White Terrier 171 (1.63) 164 (95.91)
Maltese 317 (3.02) 309 (97.48)
Total 10 481 (100) 9906 (93.72)
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confirmed substantial differences in antibody response in
different breed groups (P < 0.001). FCI 5 consisting of
Primitive type and Spitz dogs was the category with the
lowest vaccination success rate (89.38%), while FCI 3 and
FCI 9 were the best categories with a success rate not lower
than 95%. No FCI category showed a success rate higher
than that of cross-breeds. Among the pure breeds selected
for an in-depth analysis, boxers had the lowest performance
to rabies vaccination, with a success rate of 88.82%, while
the small-size breeds included in the analysis had the best
performances, regardless of the FCI group they belonged
to. Of particular note was the poor success rate of Beagles,
with only 90.32% showing a protective titre.
Dog size inversely correlated with a protective titre, with
a success rate ranging from 92.93% in giant to 95.48% in
small-size dogs.
When considering age as a risk factor, those < 1 year
showed the lowest probability of reaching the protective
threshold for antibody titre (90.33%).
Multivariate analyses
Data set A
Results from Models 1 and 2 indicated that there was no
association between time from vaccination to sampling and
outcome, when animals were inoculated with vaccine I. On
Table 1. (Continued)
Variables Categories Observations [n (%)] Positive observations*[n (%)] Cramer’s V
Group Eastern Europe
Vaccine I 162 (18.37) 124 (76.54) 0.1491
II 709 (80.38) 631 (89.00)
III 11 (1.25) 11 (100.00)
IV 0 (0) 0 (0)
Total 882 (100) 766 (86.85)
VtSa ≤15 1 (0.11) 1 (100) 0.2023
16–30 29 (3.29) 18 (62.07)
31–45 49 (5.56) 34 (69.39)
46–60 35 (3.97) 35 (100)
61–75 5 (0.57) 5 (100)
>75 762 (86.50) 672 (88.19)
Total 881 (100) 765 (86.83)
*Titres ≥ 0.5 IU/ml.
aVtS: time from vaccination to sampling, expressed as days post-vaccination.
bFCI: International Canine Federation. FCI 1: Sheepdogs and Cattle dogs other than Swiss Cattle dogs); FCI 2: Pinschers, Schnauzers, Molossoid and
Swiss mountains and Cattle dogs; FCI 3: Terriers; FCI 4: Dachshunds; FCI 5: Primitive type and Spitz dogs; FCI 6: Scent hounds and related breeds; FCI
7: Pointers and Setters; FCI 8: Retrievers, Water Dogs and Flushing Dogs; FCI 9: Companion and Toy dogs; FCI 10: Sighthounds.
cSmall: ≤10 kg; medium: 11–25 kg; big: 26–44 kg; giant: ≥45 kg.
dThe variable age was organized into 11 categories, but included in the model as a continuous variable.
eObservations collected from 8 breeds were selected from group Italy sub-data set and performances compared to those of cross-breeds.
Bold values correspond to the total observations (and percentages) for each variable considered in the study.
Table 2. Multivariate models with only significant variables (P < 0.05). Three models were applied to data set A, observations from dogs living in Italy
and sampled before the intended travel. In Model 4, the interaction between the vaccine and the dog of geographical origin, intended as group Italy
and group Eastern Europe (dogs entering Italy from an Eastern European country) observations, was assessed
Data sets Multivariate models Observations
Independent variables
InteractionsVaccine Age VtS Breed (FCI) Size Breeda Origin
Data set A Model 1 19 670 +b + + + Vaccine * VtS
Model 2 18 485 +b + + + Vaccine * VtS
Model 3c 10 278 + + +
Data set B Model 4 20 991 +d + + Vaccine * VtS
Vaccine * Origin
aObservations collected from 8 breeds were selected from group Italy sub-data set and performances compared to those obtained from cross-breeds.
The selected breeds were English Setter, Pinscher, Chihuahua, Maltese, West Highland White Terrier, German Shepherd, Boxer, Beagle.
bThree vaccine categories (I, II and III) included.
cResults not shown.
dTwo vaccine categories (I and II) included.
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the contrary, vaccines II and III showed an increasing likeli-
hood of higher titres as time progressed over the first two
months. The relationship between vaccine used and out-
come was explored in each category of VtS. Vaccine I
showed much better performances, ranging from an odds
ratio of two to more than four times higher than vaccine II
in each category of sampling time. Vaccines II and III dis-
played similar results, except for samples collected between
sixteen to thirty days p.v., where vaccine III showed an
odds ratio more than twice higher (Table 3a).
According to the results of Model 1, animals belonging to
FCI categories 2, 5 and 6 showed the lowest odds of yielding
neutralizing titres ≥ 0.5 IU/ml when compared to cross-
breeds (P ≤ 0.01) (Table 3b, Model 1), with FCI category 5
showing the poorest response. Model 2 (including size
instead of breed) showed equivalent results to Model 1 for
the independent variables contained in both models. In
addition, Model 2 indicated that, in comparison with smaller
breeds, medium and big size breeds have a lower probability
of reaching a positive outcome (P < 0.01), which means that
the greater the size, the worse the response to vaccination
(Table 3b, Model 2). Model 3 revealed that cross-breeds had
a higher probability of reaching a protective titre compared
to the English Setter, the German Shepherd, the Boxer and
the Beagle (P ≤ 0.002) (data not shown).
In relation to the age of the animals, results from the
multivariate analyses confirmed the output from the uni-
variate analysis, with younger dogs less likely to respond
Table 3. Results of multivariate logistic regression of data set A. Table 3a presents the results for variables vaccine and time from vaccination to sam-
pling (VtS), considering an interaction between both variables, as obtained from Models 1 and 2. Table 3b presents the results obtained for the inde-
pendent variables breed (Model 1) and size (Model 2)
3a
Interaction by vaccine type Interaction by VtS
Vaccine VtS Odds ratio (95% CI) P-value VtS Vaccine Odds ratio (95% CI) P-value
I <15 1 (–) – <15 I 3.53 (1.23–10.14) 0.019
16–30 1.29 (0.55–3.03) 0.565 II 1 (–) –
31–45 1.79 (0.76–4.19) 0.181 III 0.86 (0.24–3.01) 0.810
46–60 2.46 (0.96–6.31) 0.061 16–30 I 1.96 (1.31–2.95) 0.001
61–75 1.26 (0.50–3.16) 0.619 II 1 (–) –
>75 0.78 (0.34–1.78) 0.551 III 2.39 (1.14–4.99) 0.021
II <15 1 (–) – 31–45 I 2.59 (1.86–3.59) <0.001
16–30 2.30 (1.10–4.84) 0.027 II 1 (–) –
31–45 2.43 (1.20–4.94) 0.014 III 1.40 (0.86–2.28) 0.176
46–60 2.01 (0.94–4.31) 0.074 46–60 I 4.32 (2.38–7.82) <0.001
61–75 1.28 (0.59–2.80) 0.535 II 1 (–) –
>75 0.80 (0.41–1.58) 0.518 III 1.55 (0.70–3.46) 0.284
III <15 1 (–) – 61–75 I 3.48 (1.95–6.21) <0.001
16–30 6.43 (1.84–22.51) 0.004 II 1 (–) –
31–45 3.97 (1.26–12.48) 0.018 III 2.17 (0.81–5.85) 0.124
46–60 3.63 (1.01–13.04) 0.048 >75 I 3.43 (2.91–4.04) <0.001
61–75 3.25 (0.81–13.09) 0.098 II 1 (–) –
>75 2.09 (0.70–6.25) 0.187 III 2.24 (1.68–3.00) <0.001
3b
Model 1 Model 2
Breed (FCI) Odds ratio (95% CI) P-value Size Odds ratio (95% CI) P-value
Cross-breed 1 (–) Small 1 (–)
FCI1 0.65 (0.46–0.91) 0.013
FCI2 0.60 (0.46–0.80) <0.001
FCI3 0.99 (0.72–1.37) 0.944 Medium 0.70 (0.58–0.86) 0.001
FCI4 0.79 (0.48–1.28) 0.337
FCI5 0.39 (0.27–0.57) <0.001
FCI6 0.52 (0.35–0.78) 0.002 Big 0.76 (0.65–0.90) 0.001
FCI7 0.79 (0.64–0.98) 0.030
FCI8 0.66 (0.50–0.87) 0.004
FCI9 0.89 (0.67–1.17) 0.407 Giant 0.72 (0.50–1.05) 0.085
FCI10 0.74 (0.41–1.34) 0.328
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satisfactorily to vaccination. For each increase in age of one
year, there was a 1.18 increase in the odds of obtaining a
positive outcome (P < 0.001) (data not shown).
Data set B
Model 4 showed that the time interval between vaccina-
tion and sampling was associated with the outcome,
with effects that were different according to vaccine
type (Table 4). Specifically, when using vaccine II, dogs
were more likely to obtain a titre ≥0.5 IU/ml between
15 and 45 days p.v. (Table 4a). Such a marked pattern
in antibody response in relation to VtS was not noticed
for vaccine I (Table 4a and 4c). Vaccines appeared to
perform differently in groups Eastern Europe and Italy.
Vaccine I showed a significantly lower likelihood of
vaccine success in group Eastern Europe than in group
Italy. The opposite effect was found for vaccine II, with
a greater likelihood of vaccine success in group Eastern
Europe, regardless of VtS (Table 4b and 4c).
Discussion
This study, based on a panel of over 20 000 observations
collected in dogs over a period of 7 years, provides an
updated analysis of variables associated with rabies vaccina-
tion response in dogs. Of interest, it also includes an analy-
sis of the observations collected from dogs entering the
Italian border both from EU and non-EU countries. Find-
ings from our study are generally in agreement with those
reported in the literature, identifying sex as the only vari-
able not associated with serological response to rabies vac-
cination in dogs (Cliquet et al., 2003; Mansfield et al.,
2004; Kennedy et al., 2007; Zanoni et al., 2010; Berndtsson
et al., 2011).
Our investigation provides evidence that the most com-
mon vaccines used in dogs have different performances.
More specifically, although the probability of a positive
outcome (serum titre ≥0.5 IU/ml) generally increased pro-
gressively from the 15th day until the 2nd month p.v., vac-
cine I seems to induce a faster and longer-lasting antibody
Table 4. Results of multivariate logistic regression of data set B. Table 4a: results for variables vaccine types and time from vaccination to sampling
(VtS); Table 4b: results for variables vaccine types and groups of geographical origin; Table 4c: results for variable vaccine types by VtS and by groups
of geographical origin (Italy or Eastern Europe)
4a 4c
Interaction between vaccine and VtS Interaction between vaccine and VtS by group of geographical origin
Vaccine VtS Odds ratio (95% CI) P-value Group VtS Vaccine Odds ratio (95% CI) P-value
I <15 1 (–) – Italy <15 II 1 (–) –
16–30 0.99 (0.45–2.19) 0.987 I 3.77 (1.38–10.31) 0.010
31–45 1.40 (0.64–3.06) 0.406 16–30 II 1 (–) –
46–60 2.35 (0.97–5.68) 0.059 I 1.65 (1.12–2.4) 0.012
61–75 1.08 (0.46–2.56) 0.859 31–45 II 1 (–) –
>75 0.66 (0.31–1.41) 0.282 I 2.33 (1.71–3.19) <0.001
46–60 II 1 (–) –
II <15 1 (–) – I 5.167 (2.88–9.24) <0.001
16–30 2.27 (1.09–4.73) 0.028 61–75 II 1 (–) –
31–45 2.26 (1.12–4.54) 0.022 I 3.56 (2.01–6.30) <0.001
46–60 1.72 (0.81–3.64) 0.159 >75 II 1 (–) –
61–75 1.15 (0.53–2.48) 0.728 I 3.58 (3.05–4.21) <0.001
>75 0.7 (0.35–1.35) 0.281 Eastern Europe <15 II 1 (–) –
4b
Interaction between vaccine and group of geographical
origin
I 0.27 (0.09–0.82) 0.021
Vaccine Group Odds ratio (95% CI) P-value
16–30 II 1 (–) –
I Italy 1 (–) – I 0.12 (0.07–0.22) <0.001
31–45 II 1 (–) –
I 0.17 (0.10–0.29) <0.001
Eastern Europe 0.12 (0.08–0.17) <0.001 46–60 II 1 (–) –
I 0.37 (0.18–0.76) 0.007
II Italy 1 (–) – 61–75 II 1 (–) –
Eastern Europe 1.59 (1.23–2.06 <0.001 I 0.26 (0.12–0.53) <0.001
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response than vaccine II. Similarly, an experimental study
identified different performances between two commercial
vaccines in terms of persistence and magnitude of the neu-
tralizing titre elicited (Minke et al., 2009), although a
breed-specific immunological limitation may have affected
the outcome of this study based on conventional laboratory
Beagles, as previously reported (Van de Zande et al., 2009).
Our research has also identified a marked difference in
the way vaccines perform in different geographical areas.
Interestingly, vaccine I was administered more frequently
and had the best performance in group Italy, while vaccine
II was the most commonly used in group Eastern Europe,
where it performed better than in group Italy. Such a dis-
crepancy may be due to the conditions in which the two
vaccines are produced, distributed and stored in different
countries, although the authors acknowledge that differ-
ences in their use (i.e. route of administration or site of
injection) cannot be totally excluded.
These findings suggest that the choice of the vaccine may
influence the likelihood of an animal achieving a protective
serological titre and that VtS should be considered when
interpreting the serological test results.
In agreement with previously reported findings (Mans-
field et al., 2004; Kennedy et al., 2007; Zanoni et al., 2010;
Berndtsson et al., 2011), young dogs in our study showed a
lower probability of achieving a positive outcome, with a
steadily increasing success rate in adult dogs up to the age
of 9 and declining thereafter. This finding is not unex-
pected, based on the dog immune system development and
senescence (Day, 2007, 2010) and previously reported evi-
dence that rabies vaccination induces a significantly lower
response in old dogs than in adult ones (12.1  1.3 and
3.15  0.8 years, respectively) (HogenEsch et al., 2004).
Our study found a positive association between age and
outcome, even when controlling the confounding effect of
size on the basis that life expectancy in dogs is usually
inversely correlated with size (Kraft, 1998; Michell, 1999;
Kraus et al., 2013).
Cross-breeds and FCI categories 3, 4, 9 and 10 showed the
best response to vaccination, while FCI categories 2, 5, and 6
had the poorest response. Among the breeds studied inde-
pendently from FCI group, the Boxer and the Beagle are
worth a special mention, as they showed a remarkable failure
rate (11.18% and 9.68%, respectively). While the inability of
Beagles to effectively respond to vaccination has already been
observed (Kennedy et al., 2007; Van de Zande et al., 2009),
to our knowledge such an unexpectedly high rabies vaccine
failure in Boxers has never been detected before. The fact
that Beagles fall into the poor-responder category is espe-
cially noteworthy, as they are the breed most commonly
used for vaccine trials, and it has been argued that vaccine
performances and kinetics in this breed may not be truly
representative (Van de Zande et al., 2009).
We found an overall 6.19% failure rate, in line with pre-
vious estimations in Europe (1.1–11.1%) (European Food
Safety Authority, 2006). Higher failure proportions have
been previously found in specific contexts, such as a 37%
vaccine failure rate in dogs sampled at the Italian border
(De Benedictis et al., 2008) and a more recently a 53% fail-
ure rate in rescued dogs from Romania and Hungary to
Norway (Klevar et al., 2015). Similarly, we found a higher
vaccine failure rate in dogs entering Italy from foreign
countries (13.15%) than in those vaccinated in Italy
(5.89%). Several factors should be considered as possible
causes of an unfavourable post-vaccination outcome (Blan-
cou et al., 1983), and most of them have been extensively
discussed. Vaccine failure may be ascribable to most of the
animals tested >75 days p.v. (86.5% and 43.19%, in groups
Eastern Europe and Italy, respectively). Interestingly, the
discrepancy in vaccine failure rates for this category
>75 days p.v. is still significant between the two groups,
meaning that even when testing >75 days after vaccination,
the vaccination response is truly different in both groups.
Interestingly, a significant difference between success rates
obtained in Swedish owned dogs rather than in stray ones
from Romania and Hungary and sampled within this same
time lapse has been noticed (85.7% versus 45.5%, respec-
tively, P < 0.0001), which may suggest poor compliance
with the current EU regulation (Klevar et al., 2015).
One possible explanation for the poorer vaccination
response in group Eastern Europe could be transport-
related stress, as most observations from this group were
made on dogs subject to commercial transport, which may
not always be in line with international rules (Fevre et al.,
2006; Tietjen et al., 2011; Klevar et al., 2015). In such cases,
a failure in vaccine response may be attributed to counter-
feit vaccine certificates and/or to the vaccination of puppies
prior to the recommended 12 weeks, as frequently
documented (European Parliament 2012: http://www.eu
roparl.europa.eu/sides/getDoc.dotype=WQ&reference=E-2012-
007168&language=EN) (Tietjen et al., 2011).
According to the results of our study and to the available
literature, border controls still have a key role in assessing the
full compliance of pet movements with EU legislation, and
they should therefore be run timely and efficiently, not only
to prevent the introduction of diseased pets into rabies-free
areas, but to ensure that the animal welfare is maintained to
an acceptable standard during international transport.
Limitations of the study
All observations were collected as part of routine antibody
titration activities at the IZSVe, not specifically for the aim
of this study. Being a retrospective analysis of a pre-existing
database, we were not able to identify any potential data
entry errors, or mistakes, made when filling in the
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accompanying submission forms Information on the fac-
tors of interest was available for a great number of dogs,
resulting in a large database for our analysis, which con-
tributed to the reliability of our results. Nevertheless, the
data set lacked details of other very relevant factors that
could be associated with the outcome of vaccination suc-
cess or failure. For instance, information on whether the
vaccine was administered alone (e.g. in monovalent form)
or in combination with other vaccines was not recorded.
Similarly, the database only contained the date of the last
rabies vaccination, with no information on whether the
animals had received any other rabies vaccine injections
before the reported one. The administration type (intra-
muscular versus subcutaneous) was unknown. We cannot
therefore exclude the possibility of other additional factors
influencing the associations found in this study.
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